The nuclear factor‐κB (NF‐κB) transcription factor family has been considered the central mediator of the inflammatory process and a key participant in innate and adaptive immune …
S Hu, ZY Xu-Monette, A Tzankov… - Blood, The Journal …, 2013 - ashpublications.org
Diffuse large B-cell lymphoma (DLBCL) is stratified into prognostically favorable germinal center B-cell (GCB)–like and unfavorable activated B-cell (ABC)–like subtypes based on …
M Roschewski, LM Staudt, WH Wilson - Nature reviews Clinical …, 2014 - nature.com
Diffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell non-Hodgkin lymphoma that affects patients of all ages with a wide range of clinical presentations. Although DLBCL is …
M Zhao, P Chauhan, CA Sherman, A Singh… - Nature …, 2023 - nature.com
The nuclear factor kappa B (NF-κB) family of transcription factors orchestrates signal- induced gene expression in diverse cell types. Cellular responses to NF-κB activation are …
Y Wang, Z Xu, KL Wu, L Yu, C Wang… - Proceedings of the …, 2024 - National Acad Sciences
Immunotherapy is a promising approach for treating metastatic breast cancer (MBC), offering new possibilities for therapy. While checkpoint inhibitors have shown great progress in the …
The NF-κB transcription factor pathway is a crucial regulator of inflammation and immune responses. Additionally, aberrant NF-κB signaling has been identified in many types of …
The nuclear factor‐κB (NF‐κB) signaling pathway is a busy ground for the action of the ubiquitin–proteasome system; many of the signaling steps are coordinated by protein …
C Giuliani, I Bucci, G Napolitano - Frontiers in endocrinology, 2018 - frontiersin.org
Nuclear factor-kappa B (NF-κB) is a ubiquitous transcription factor that is involved in inflammatory and immune responses, as well as in regulation of expression of many other …
AS Baldwin - Immunological reviews, 2012 - Wiley Online Library
The cellular response to survive or to undergo death is fundamental to the benefit of the organism, and errors in this process can lead to autoimmunity and cancer. The transcription …